Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum
- PMID: 22733074
- PMCID: PMC3421891
- DOI: 10.1128/AAC.00488-12
Molecular identification and in vitro response to antifungal drugs of clinical isolates of Exserohilum
Abstract
Exserohilum is an agent of human and animal mycoses. Although classification has been based on a few subtle morphological differences, three species of clinical interest have been traditionally accepted. In this study, by using a multigene sequence analysis, we have demonstrated that Exserohilum longirostratum and E. mcginnisii are probable synonyms of E. rostratum. The isolates tested were mainly from the nasal region. Antifungal susceptibility testing demonstrated high activity of the eight agents tested against this fungus.
References
-
- Adler A, et al. 2006. Exserohilum: an emerging human pathogen. Eur. J. Clin. Microbiol. Infect. Dis. 25:247–253 - PubMed
-
- Al-Attar A, Williams CG, Redett R. 2006. Rare lower extremity invasive fungal infection in an immunosuppressed patient: Exserohilum longirostratum. Plast. Reconstr. Surg. 117:44e–47e - PubMed
-
- Alvarez E, et al. 2010. Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species. Rev. Iberoam. Micol. 27:80–89 - PubMed
-
- Arredondo-García JL, Amábile Cuevas CF, RedMic2 Study Group 2009. Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals. J. Infect. Dev. Ctries. 3:398–401 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
